Sign in
WithdrawnNo phase

Neurobiomarker for Prism Adaptation Treatment Response

Key facts

Who runs it
University of Utah
Where
Salt Lake City, United StatesSee the site
Trial code
Status
Withdrawn
Started
1 Jan 2023
Ended
5 Dec 2024
Type of study
Interventional
Treatments tested
  • Prism Adaptation Therapy
Record updated
17 June 2025
Why it stopped
no time to complete study in this format

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • 1) within 1 month of right hemisphere stroke; suspected of having unilateral spatial neglect; able to provide consent; likely to remain in rehabilitation for 10-12 days or willing to return to the University to complete 10 sessions of treatment and post-treatment testing; able to have an MRI; will be or has been admitted to the Craig H. Neilson Rehabilitation Hospital for rehabilitation or is able to come to the Craig H. Neilson Rehabilitation Hospital for prism adaptation therapy sessions; age 18-90 years; able to sit in a wheelchair or other chair for 1 hour; able to point straight ahead and hold a pen with right hand

Who cannot take part

  • 1) other neurologic, medical that would interfere with ability to complete the testing or training; no uncorrected visual or hearing problems, other than hemianopsia; contraindications to MRI; unable to provide consent due to significant aphasia or cognitive impairment

Where in United States

  • University of UtahSalt Lake City, United States

About the trial

What the trial wants to find out

Preliminary data will be collected about which individuals with spatial neglect from right hemisphere stroke (aiming vs perceptual neglect) improve with Prism Adaptation Training and if there is a particular pattern of damage in the brain that predicts both the type of neglect experienced and whether neglect is improved following Prism Adaptation Training

The group in the trial

  • Prism Adaptation TherapyTreatment being tested

    10 sessions (60 trials each) 1x/day of Prism Adaptation Therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of a Neuroimaging Biomarker to Identify Optimal Candidates for Prism Adaptation Treatment
Record updated
17 June 2025